Showing results (1-10 of 237) with videos related to
Sort By:
Pageof 24
Cancer Biology & Therapy|June 8, 2011
Src family kinases and paclitaxel sensitivityXiao-Feng Le, Robert C BastCell Cycle (Georgetown, Tex.)|December 22, 2004
HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathwaysXiao-Feng Le, Franz Pruefer, Robert C BastCancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|January 7, 2011
The Roles of MicroRNAs in the Cancer Invasion-Metastasis CascadeXiao-Feng Le, Omar Merchant, Robert C Bast, et al.Cancer|July 15, 2010
Dasatinib induces autophagic cell death in human ovarian cancerXiao-Feng Le, Weiqun Mao, Zhen Lu, et al.Molecular Cancer Therapeutics|November 21, 2007
Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cellsXiao-Feng Le, Aruni S Arachchige-Don, Weiqun Mao, et al.Cell Cycle (Georgetown, Tex.)|November 26, 2008
Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2Xiao-Feng Le, Weiqun Mao, Chunhua Lu, et al.Oncogene|January 30, 2003
Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosisXiao-Feng Le, Walter N Hittelman, Jiaxin Liu, et al.The Journal of Biological Chemistry|April 18, 2003
The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibitionXiao-Feng Le, Francois-Xavier Claret, Amy Lammayot, et al.Cancer Chemotherapy and Pharmacology|February 23, 2011
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancerAhmed Ashour Ahmed, Juliet Goldsmith, Izabela Fokt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Status of tumor markers in ovarian cancer screeningRobert C BastPageof 24